OnDemand WTP Pricing Research

Lawmakers Halt Push for Drug Prices in TV Ads | RAPS

In an effort to get the first set of FY 2019 appropriations bills to the President’s desk, US House leaders scrapped a bipartisan amendment that would have required drugmakers to include list prices in direct-to-consumer (DTC) television ads.

The amendment—sponsored by Sens. Dick Durbin (D-IL) and Chuck Grassley (R-IA)—was offered and subsequently withdrawn during a joint conference committee of the House and Senate, despite passing the Senate last month. The move was followed by finger pointing.
The amendment forms part of an ongoing effort to combat drug prices through greater transparency. It is also a pillar to the Trump administration’s recent “blueprint” on drug prices.

“For some reason, someone on the other side is trying to block this common sense, truly bipartisan policy,” Durbin said during the joint hearing. “When are we going to stand up to Big Pharma and actually do something about sky high prescription drug prices? Transparency in advertising is the very least Congress can do,” Durbin added.

Read complete article here:

Lawmakers Halt Push for Drug Prices in TV Ads | RAPS.